5mg 100ml Zoledronic Acid Infusion

5mg 100ml Zoledronic Acid Infusion Specification

Dosage Form
Infusion

Pacakaging (Quantity Per Box)
1 Bottle per box

Indication
Osteoporosis, Hypercalcemia associated with cancer, Pagets disease

Life Span
24-36 months from manufacturing date

Packaging Type
Infusion bottle/vial

Origin of Medicine
India

Brand Name
Zoledronic Acid Infusion 5mg/100ml

Salt Composition
Zoledronate (Zoledronic Acid) 5mg

Drug Type
Intravenous Bisphosphonate Injection, Bisphosphonate (Bone resorption inhibitor)

Ingredients
Zoledronic Acid 5mg

Physical Form
Liquid (Infusion Solution), Liquid Infusion

Function
Bisphosphonate for bone health, prevents bone resorption, Prevention and treatment of bone-related disorders

Recommended For
Osteoporosis, Hypercalcemia of malignancy, Pagets disease of bone

Dosage
5 mg as a single intravenous infusion per bottle

Dosage Guidelines
Should be administered by a healthcare professional as a single infusion once a year or as directed

Suitable For
Adults, Adults

Quantity
100 ml per vial

Storage Instructions
Store below 25C, protect from light, do not freeze

Secondary Packaging
Each bottle individually packed with leaflet in cardboard box

Contraindications
Renal impairment, hypersensitivity to Zoledronic Acid or other bisphosphonates

Registration Status
Prescription only medicine (Rx)

Use Under Medical Supervision
Yes

Infusion Time
At least 15 minutes

Appearance
Clear, colorless, sterile solution

Administration Route
Intravenous infusion

Shelf Life
2 years from manufacture date

Manufacturing Standard
WHO-GMP/ISO certified facility

Common Side Effects
Fever, bone pain, hypocalcaemia, fatigue

5mg 100ml Zoledronic Acid Infusion Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 5mg 100ml Zoledronic Acid Infusion

Unlock matchless efficacy with Zoledronic Acid Infusion 5mg/100ml, your redoubtable ally in the management of osteoporosis, hypercalcemia of malignancy, and Paget's disease of bone. Procure a clear, sterile solution engineered to WHO-GMP/ISO standards, presenting triumphant results in the prevention of bone resorption. With a markdown on adverse episodes, this prescription-only medicine is administered as a single intravenous infusion over at least 15 minutes. Each box delivers unrivaled safety, with meticulous secondary packaging and an informative leaflet. Use strictly under expert medical supervision.

Targeted Bone Health Therapy: Usage & Application

Zoledronic Acid Infusion 5mg/100ml is expertly crafted for intravenous use, administered only by a healthcare professional. This solution is specifically recommended for adults battling osteoporosis, hypercalcemia associated with cancer, and Paget's disease. Its primary function is to inhibit bone resorption, promoting stronger bones and improved health outcomes. Designed for in-hospital application, this infusion is sourced from WHO-GMP/ISO-certified plants, ensuring matchless purity and consistent quality for all users.

Reliable Delivery, Sample Policy, and Transportation

Experience streamlined transportation and prompt arrival with every Zoledronic Acid Infusion 5mg/100ml order. Samples are available to facilitate evaluation before substantial outlay, with a transparent sample policy designed for supplier and trader confidence. Each bottle is securely packed to maintain integrity during transit, ensuring quality upon arrival. Allow ample time for delivery, as outlined by the supplier, to ensure you receive this vital medicine when you need it most.

FAQ's of 5mg 100ml Zoledronic Acid Infusion:

Q: How should 5mg 100ml Zoledronic Acid Infusion be administered?

A: This infusion must be given intravenously over at least 15 minutes by a qualified healthcare professional in a medical setting.

Q: What conditions does Zoledronic Acid Infusion primarily treat?

A: It is indicated for osteoporosis, hypercalcemia of malignancy, and Paget's disease of bone, offering therapeutic benefit in the prevention and treatment of these bone-related disorders.

Q: When should this medication be avoided?

A: Avoid Zoledronic Acid Infusion if you have significant renal impairment or a known hypersensitivity to zoledronic acid or other bisphosphonates.

Q: Where is Zoledronic Acid Infusion manufactured and how is it packaged?

A: It is manufactured in a WHO-GMP/ISO certified facility in India and each bottle is individually packed with a leaflet in a cardboard box for quality assurance.

Q: What are the major benefits of using this medicine?

A: The infusion delivers triumphant results in reducing bone resorption, improving bone strength, and managing complications from certain cancers affecting bone.

Q: What side effects can occur with Zoledronic Acid Infusion?

A: Common side effects include fever, bone pain, hypocalcemia, and fatigue. All patients should be monitored by a healthcare provider after administration.